Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. 薬物誘発性肝障害の関連リスク評価 対象DB:VigiBase
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System. グルカゴン様ペプチド-1(GLP-1)受容体作動薬と網膜有害事象との関連性評価 対象DB:FAERS
Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System. スタチン使用に関連する筋萎縮性側索硬化症(ALS)様症状関連性評価 対象DB:FAERS